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INTRODUCTION
The metabolic syndrome is a cluster of clinical and metabolic
abnormalities first described by Reaven (1988). Subjects with the
metabolic syndrome have an increased risk of developing type 2
diabetes mellitus, cardiovascular disease and thrombosis (Grundy
et al. 2004). Both genetic and environmental factors are involved
in developing the syndrome.
It is now recognised that a pro-inflammatory state and endothe-
lial dysfunction underlie the changes that promote atherosclerosis
and cardiovascular disease in subjects with the metabolic syn-
drome. Levels of inflammatory markers such as C-reactive pro-
tein (CRP), cytokines such as interleukin 6 (IL6), tumour necro-
sis factor-α (TNF-α), levels of procoagulants for example fib-
rinogen and fibrinolytic inhibitors for example plasminogen acti-
vator inhibitor (PAI-1) are chronically increased in the plasma of
subjects with the metabolic syndrome, reflecting the inflammato-
ry and prothrombotic milieu.
Highly sensitive C-reactive protein (HS-CRP) and fibrinogen
are markers of vascular inflammation in conditions such as ather-
osclerosis and the metabolic syndrome. Their raised levels indi-
cate endothelial damage (Libby et al. 2002; Ridker et al., 2001).
CRP is also produced in response to release of cytokines (IL-6,
TNF-α) by the the visceral fat where a low grade inflammatory
response exists in subjects with the metabolic syndrome (Yudkin
et al. 1999). The MONICA study recently analysed the relation-
ship between the levels of markers of systemic inflammation
associated with cardiovascular disease and overall alcohol intake.
The levels of markers such as fibrinogen and CRP were found to
be significantly lower in moderate alcohol users compared to
non-drinkers and heavy drinkers, suggesting that ethanol itself
might have an anti-inflammatory effect (Imhof et al. 2004).
Platelets play an important role in thrombosis and in myocar-
dial infarction (Ross, 1999). Platelets in essential hypertension
show an increased tendency to aggregate (Nityanand et al. 1993)
due to platelet activation under conditions of increased shear
force and endothelial dysfunction (Blann et al. 2003). Platelets of
diabetics are more aggregable than those of normal subjects
(Tomaselli, 1990) and are more resistant to the antithrombotic
effects of aspirin due to several factors, for example insulin resis-
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tance can also occur in platelets (Evangelista et al. 2004).
Treatment of the metabolic syndrome in the early phase before
vascular and diabetic complications become manifest, is directed
towards weight reduction and includes rigorous dieting with car-
bohydrate and fat intake restriction and increase in physical exer-
cise (Lavrenic et al. 2000). Through epidemiological studies, evi-
dence is accumulating that a Mediterranean diet has anti-athero-
genic and cardioprotective effects (Keys et al. 1986; De Lorgeril
et al. 1999; Trichopoulou, 2003). Eposito et al. (2004) reported a
favourable response in subjects with the metabolic syndrome on
a Mediterranean diet as opposed to a control prudent diet.
Moderate alcohol consumption has been shown to improve
insulin sensitivity and to lower blood glucose levels (Howard et
al. 2004). The ATTICA study reported a more favourable plasma
profile of inflammatory and haemostatic markers in subjects who
consumed a diet that most closely resemble a Mediterranean diet
that included moderate wine consumption, compared to subjects
who followed a Western type diet (Chrysohoou et al. 2004). In a
controlled prospective intervention study on two groups of
healthy volunteers, it was shown that the Mediterranean diet com-
plemented by moderate red wine intake has favourable antithrom-
botic effects compared to a high fat diet complemented by red
wine (Mezzano et al, 2001). The effects of alcohol and of wine
on platelet function have been extensively researched. The find-
ings of these studies were recently reviewed by Ruf (2004) and
generally report an antithrombotic effect of moderate red wine
consumption on platelet function.
Procoagulants and anticoagulants also participate in thromboge-
nesis: Factor VII (FVII) levels are affected by dietary triglycerides
(Miller et al. 1986). The levels of Factor VIII (FVIII), fibrinogen
and von Willebrand’s factor (vWF) are all affected by inflamma-
tory responses (Morishita et al. 1996). The latter is also used as a
marker of endothelial function (Blann and Taberner, 1995).
From a genetic perspective, an increased level of fibrinogen is
associated with the β-fibrinogen polymorphism, β-fib, 455G→A
in the β-chain of fibrinogen. The A-allele promotes a strong acute
phase response. Homozygotes have a 7-10% higher level of fib-
rinogen with an increased rate of basal transcription (Van‘t Hooft
et al. 1999). An increase in 1 g/L fibrinogen increases the relative
risk for coronary heart disease by 1.8 with added risk for individ-
uals with diabetes or hypercholesterolaemia.
Glycoprotein IIb/IIIa (GPIIIa) is the platelet surface receptor
for fibrinogen binding. The common 1565T→C polymorphism in
exon 2 of the GPIIIa gene is associated with increased platelet
aggregability and myocardial infarction (Weiss et al. 1996). This
Leu33Pro amino acid substitution (PIA2 or HPA-1b) results in a
conformational change in the amino-terminal disulfide loop
involved in fibrinogen binding (Honda et al. 1995) and highlights
the important role of increased platelet activation in the develop-
ment of vascular disease (Cassar et al. 2003; Cherian et al. 2003).
Finally the fibrinolytic pathway’s efficiency to resolve a formed
thrombus, plays an important role via tissue plasminogen activator
(tPA) and plasminogen activator inhibitor-1 (PAI-1) activities.
Although the fibrinolytic inhibitor, PAI-1 is not considered an
independent cardiovascular disease risk marker, elevated levels are
associated with increased risk for arterial disease, thrombosis,
obesity, metabolic syndrome, insulin resistance, type II diabetes
and correlate with smoking and hypertriglyceridaemia (Loskutoff
et al. 2000). The 4G/5G insertion-deletion polymorphism at
nucleotide position –675 upstream of the PAI-1 gene affects gene
transcription and the highest levels are found with two copies of
the 4G allele (Panahloo et al. 1995). Presence of the 4G allele
increases the risk of obesity 2 to 3-fold. Variable results for these
fibrinolytic markers in relation to wine and/or alcohol consump-
tion were described before, reviewed by Rotondo et al. (2000).
OBJECTIVES
The aim of our study was to evaluate the added effect of moder-
ate red wine consumption to the Mediterranean-like diet on car-
diovascular risk factors in subjects with the metabolic syndrome.
The end points were the observed changes in risk factors (throm-
botic and inflammatory parameters) after 4 weeks of the diet and
after 4 weeks of the diet plus wine intervention. The response to
intervention was also related to the genotype of the participants in
an attempt to assess the potential impact of gene-diet interaction.
MATERIALS AND METHODS
Twelve non-smoking subjects aged 32 to 60 years on minimal
medication, were selected by exhibiting 2 or more diagnostic cri-
teria of the metabolic syndrome: central obesity (waist circum-
ference >102 cm, males; >88 cm, females); increased blood pres-
sure (>130 mmHg systolic, >85 mmHg diastolic); increased fast-
ing blood glucose (>6.1 mmol/L) (Adult Treatment Panel III,
2001). They consumed a Mediterranean-like diet for 4 weeks
without and with red wine, respectively. During the experimental
periods the subjects increased their intake of vegetables, cereals,
fruit, mono-unsaturated fatty acids (in the form of olive and can-
nola oils) and fish at the expense of red meats and dairy products.
Clear dietary guidelines were provided in the form of a lecture
and instruction booklet. Patients were motivated to include 20 –
30 minutes of mild exercise (walking) into their daily routine.
Dietary control was through 3 times 3-day dietary records at the
end of the 2 week abstention from alcohol period preceding the
interventions and during the third week of each intervention peri-
od. The amount of red wine added to the diet was 250 ml (26
grams of alcohol) per day for male and 180 ml (19 grams) per day
for female participants. A genetic profile for cardiovascular risk
factors was obtained for all the subjects to evaluate the potential
impact of genetic risk factors on response to intervention. Genetic
testing combined with medical and nutrition therapy has the
potential to translate into effective risk reduction intervention
(Fisler and Warden, 2005; Kotze and Badenhorst, 2005).
Biochemical and haemostatic parameters that reflect the risk fac-
tors for cardiovascular disease, were determined on all partici-
pants to compare the effect of their habitual and newly acquired
lifestyles and diet with and without wine. Fasting blood samples
were taken at baseline, after 4 weeks of diet and after another 4
weeks of diet plus moderate red wine consumption. Weight, waist
circumference and blood pressure were measured and the dietary
records collected and checked by the dietician at each visit.
Biochemical and physical results are reported elsewhere in this
issue (van Velden et al., 2007).
Haemostatic and inflammatory parameters
Platelet aggregation and lag time on stimulation with collagen
1 and 5 mg/ml were determined on platelet rich plasma in a
Coulter Chronolog aggregometer with Agrolink software
(Beckman-Coulter) according to a standardized method (Yardu-
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mian et al. 1986). As control, aggregation in response to arachi-
donic acid 75 µM was tested on all participants at every visit.
Plasma thromboxane B2 (TxB2) was determined by a standard
EIA method (Amersham).
Platelet activation was determined by flow cytometry as
platelet H2O2 fluxes linked to stimulation of platelets by collagen
according to the method of Del Principe et al. (1991). Catalase
was used as inhibitor and to simulate the quenching role of red
wine phenolic compounds in some of the ex vivo assays. In these
assays platelets suspended in autologous plasma were pre-incu-
bated with catalase for 30 minutes in the dark before collagen
addition and immediate assessment by flow cytometry.
The oxygen radical absorbance capacity (ORAC) assay of Ou
et al. (2001) was used to measure the anti-oxidant effect of the
diet and wine intervention respectively on the plasma after wine
and/or diet and compared to base line values. EDTA plasma was
separated and frozen immediately after venepuncture to prevent
oxidation.
Fibrinolytic parameters, tissue plasminogen activator (tPA) and
plasminogen activator inhibitor-1 (PAI-1) were determined by stan-
dardized EIA methods (Asserachrome, Stago); haemostatic para-
meters FVII and FVIII were determined by the one-stage factor
assay using factor VII and FVIII deficient plasmas (Dade Behring)
according to standardised methods (Laffan and Bradshaw, 1995).
von Willebrand’s factor (vWF) was determined by a latex enhanced
immunoassay on the ACL 9000 (Instrumentation Laboratory).
Inflammatory parameters measured were fibrinogen, deter-
mined by the Clauss method, and HS-CRP determined by neph-
elometry (Immage Nephelometer, Beckman-Coulter). The bio-
chemical tests included fasting blood glucose, insulin and
lipograms and were determined by standard methods.
The phenolic compounds of the red wines consumed in the pro-
ject, were determined and quantified by HPLC (Distell/ Infruitec).
Genotyping for cardiovascular risk factors were performed by
using a strip-assay technique based on the polymerase chain reac-
tion PCR) based method (Kotze and Thiart, 2003). The genetic
risk factors analysed for inclusion in this study were the E4 allele
of the apolipoprotein E (ApoE) polymorphism, 455G→A in the
β-fibrinogen gene, 1565T→C in the glycoprotein IIb/IIIa
(GPIIIa) gene and the 4G/5G polymorphism in the plasminogen
activator inhibitor-1 (PAI-1) gene.
RESULTS AND DISCUSSION
Platelet studies
Platelet aggregation and lag time with the different concentra-
tions of collagen showed no significant changes after the inter-
vention periods compared to baseline values with similar findings
for TxB2 levels.
Platelet fluxes with collagen and with collagen plus catalase
decreased significantly after the diet without red wine (p < 0.01 for
both) compared to baseline levels. H2O2 fluxes in platelets also
decreased after wine with diet compared to baseline levels but less
significantly. (Figs 1A and B). These findings suggest that both
interventions had an anti-oxidant effect on the platelets by lower-
ing the oxidative burst on collagen stimulation (Pignatelli et al.
1991). However, it was not reflected in the platelet aggregation
response to collagen in this study.
Inflammatory markers
The inflammatory markers were particularly high in some of the
participants. Neither CRP nor fibrinogen levels changed signifi-
cantly after any of the interventions. There was a direct correla-
tion between fibrinogen and CRP levels at baseline (r = 0.82,
p < 0.01) but after adjustment the correlation was no longer sig-
nificant (Fig. 2A). There was also a direct correlation between
fibrinogen and CRP levels after wine with diet (r = 0.87,
p < 0.001 that remained significant after adjustment (r = 0.66,
FIGURE 1A
Platelets were obtained from platelet rich plasma, washed in posphare buffered
saline (PBS), resuspended in PBS before incubation with 5µM 2,7-dichlorofluo-
rescin diacetate (DCFH2-DA) for 15 minutes in the dark. Fluorsescence was
immediately read in a Becton-Dickinson flow cytometer after addition of 10
µg/ml collagen, final concentration. All measurements were taken between 510
and 540 nm after excitation at 488 nm. The mean percentage fluorescence ± 2 SD
is given at baseline (12 participants); after diet (8 participants) and after wine plus 
diet (12 participants).
FIGURE 1B
Method and reading on the flow cytometer was similar to that described in Fig.
1A except that the PBS-resuspended platelets were first incubated with 500U/ml
catalase before the addtion of DCFH2-DA. The mean percentage fluorescence ± 2
SD is given at baseline (12 participants); after diet (8 participants) and after wine 
plus diet (12 participants).
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TABLE 1
Results of platelet function, haemostatic and inflammatory tests on 12 participants at baseline, after diet and after wine plus diet inter-
ventions given as mean ± 2 SD.
Test Baseline Diet Wine + Diet *p-value
%Aggreg Coll 1 56.67±10.6 73.17±.6.1 64.08±7.4 0.27
Coll 1 lag sec 73.42±7.85 74.6±5.58 79.08±8.3 0.56
%Aggreg Coll 5 73.67±12.5 82.0±6.12 76.33±8.94 0.715
Coll 5 lag sec 42.17±2.13 42.17±2.72 44.08±2.4 0.5
Fluor Coll+Cat 34.69±8.28 16.89±0.71 27.88±2.87 0.005
Fluor Coll 51.93±9.85 21.41±2.22 32.94±4.55 0.006
TxB2 pg/well 1.96±0.41 2.06±0.28 2.37±0.72 0.82
Fibrinogen g/L 4.84±0.31 4.83±0.37 4.57±0.45 0.52
FVII % 135.83±5.22 144.42±6.06 147.83±5.68 0.031
FVIII % 110.08±15.09 121.83±15.54 118.25±15.48 0.028
VWF % 142.17±12.42 142.08±11.53 143.33±11.63 0.936
TPA ng/ml 6.33±0.87 6.51±0.99 6.74±0.7 0.861
PAI-1 ng/ml 53.52±12.04 57.96±8.63 65.83±12.24 0.372
ORAC mmol/L TE 7.45±0.40 9.31±0.714 8.52±0.32 0.043
CRP mg/L 6.29±1.97 6.91±2.73 6.64±2.43 0.733
*p-values reflect differences between the base line and the interventions. Abbreviations: Aggreg = aggregation; Coll = collagen; lag = lag time; Fluor = fluorescence; 
Cat = catalase.
p < 0.05) (Fig. 2B). This could imply that the diet without the
wine had an attenuating effect on the inflammatory markers.
Coagulation and fibrinolytic parameters
Procoagulants FVIII, vWF and fibrinolytic parameters tPA and
PAI-1 levels did not change significantly after any of the interven-
tions. FVII levels increased after the intervention periods, signifi-
cantly after diet compared to baseline (p < 0.05) (Fig. 3). PAI-1
levels were in the upper normal range (normal range 4-43 ng/ml)
and increased after wine consumption. Results are given in Table 1.
Antioxidant parameters
The Mediterranean-like diet without wine had a protective
antioxidant effect in the plasma. There was a statistically signifi-
cant increase in the ORAC after the 4 week diet intervention peri-
od (Fig. 4), from 7.5 ± 1.4 mmol/L trolox equivalents (TE) to 9.3
± 2.5 mmol/L TE, (p = 0.03). This may be attributed to the olive
oil-based, alpha-linolenic acid-rich, Mediterranean-type diet. The
ORAC decreased slightly when wine was added to the diet, to 8.5
± 1.1 mmol/L TE, but this was not statistically significant 
(p = 0.342), and the increase in the ORAC was still significantly
different from the baseline concentration (p = 0.04).
When the ORAC levels were correlated with the other parame-
ters, a significant negative correlation (r = - 0.67, p < 0.05) was
found with CRP only after the 4 week wine and diet intervention
period (Fig. 5). This finding suggests an anti-inflammatory effect
of anti-oxidants in red wine. A similar trend was found with fib-
rinogen (r = - 0.56, p = 0.06). No significant correlations were
found between ORAC levels and the other haemostatic inflam-
matory markers (vWF, FVIII or PAI-1).
FIGURES 2A AND B
The concentrations of fibrinogen are plotted against those of HS-CRP at base line (A) and after wine plus diet (B) for the 12 participants. Direct linear relations were found 
with r-value of 0.82 (p<0.005) for A and r-value of 0.87 (p<0.0005) for B.
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Epidemiological studies that correlate alcohol intake with
markers of inflammation found an inverse relation between the
amount of alcohol consumed and markers like fibrinogen, white
blood cell count and FVIII, except for CRP where the relationship
was significantly modified for subjects with the ApoE4 genotype
in subjects with no evidence for cardiovascular disease (Mukamal
et al, 2004). In our study 4 of our subjects had the ApoE4 geno-
type and their mean CRP levels were higher initially and after
both interventions than those of the ApoE4 negative subjects. The
median levels however, did not differ between the groups (Table
2) and CRP levels varied widely in both groups.
The ATTICA study reported a more favourable plasma profile
of inflammation and haemostasis markers (Chrysohoou et al.
2004) as well as significantly elevated total anti-oxidant capacity
and lower oxidized LDL cholesterol levels in individuals who
consumed a diet that most closely resemble a Mediterranean diet
which included moderate wine consumption, compared to sub-
jects who followed a Western type diet (Pitsavos et al. 2005). In
our study the plasma anti-oxidant capacity measured by ORAC
showed a significant increase after both the diet and the diet with
wine intervention periods.
Imhof et al. (2004) found general anti-inflammatory effects for
alcohol in the form of wine or beer on markers such as white
blood cell count, plasma viscosity, CRP and fibrinogen in a report
on the MONICA study. Contrary to the literature findings, red
wine demonstrated no additional anti-inflammatory or anti-
haemostatic effects in our subjects as evaluated by CRP, fibrino-
gen, vWF, FVIII, tPA and PAI-1 levels that did not change sig-
nificantly after any of the interventions. Contrary to our expecta-
tions, FVII increased significantly after diet intervention com-
pared to baseline levels which could not be explained by correla-
tions with triglyceride or weight. Similar results were also found
in another study, where addition of red wine did not add to the
benefits of a Mediterranean-like diet on the haemostatic factors
FIGURE 3
Factor VII concentration was determined by the one stage factor deficient assay
that measures and plots the prothrombin times of serial dilutions of test plasma
against serial dilutions of control plasma in FVII deficient plasma. The FVII con-
centrations of 12 partcipants are shown as the mean ± 2SD at baseline, after diet 
and after wine plus diet.
FIGURE 4
Plasma anti-oxidant potential was determined by ORAC (oxygen radical
absorbant capacity) and the mean ± 2SD as mmol/L TE are shown for the 12 par-
ticipants at baseline, after diet and after wine plus diet period.
FIGURE 5
The concentrations of HS-CRP (mg/L) when plotted against the ORAC concentra-
tions (mmol trolox equivalents) of the 12 participants showed a significant negative
correlation with an r-value of – 0.62 (p<0.05) after the wine plus diet intervention.
except for prolongation of the bleeding times (Mezzano et al.
2003). Another confounding finding was the significant correla-
tion between CRP and fibrinogen after the diet with wine period,
implying that the diet without the wine has an attenuating effect
on the inflammatory markers while the addition of wine did not.
Our study investigated the short-term beneficial effects of mod-
erate wine consumption on biological parameters. It could be that
the effect of diet and wine cannot be demonstrated in such a short
intervention period. It is also probable that the diet showed more
favourable effects on health parameters such as the anti-oxidant
capacity of the plasma because the diet was continued for double
the period of time as for that of wine intake. Wine was added last
in the intervention, however, and the beneficial anti-oxidant effect
of the diet alone could have been partially reversed by the addi-
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TABLE 2
Genotype related to phenotypic expression or functional response
Gene mutation Genotype Participants Associated effect Baseline* Diet* Diet+wine*
β-fibrinogen 455G→A GA; AA 4 Fibrinogen (g/L) 5.0 (5.2) 5.6 (5.5) 5.2 (5.0)
GG 8 Fibrinogen (g/L) 4.8 (4.6) 4.5 (4.3) 4.3 (3.8)
GPIIIa 1565T→C TC; CC 3 %aggregation 5mg/ 118 (120) 99 (99) 105 (104)
ml collagen
TT 9 %aggregation 59 (59) 76 (66) 67 (67)
5mg/ml collagen
PAI-1 -675 4G/5G 4G/5G; 4G/4G 8 PAI-1 ng/ml  47.6 (45) 55.7 (50) 64.8 (50)
5G/5G 4 PAI-1 ng/ml 65.3 (37) 62.5 (57) 68  (52)
ApoE 3937T→C TC (E3/4) 4 CRP mg/L 8.8 (5.0) 9.4 (2.0) 9.0 (3.0)
TT 8 CRP mg/L 5.7 (4.4) 6.3 (4.0) 6.1(4.0)
*Numerical values are given as mean, and as median between parentheses.
tion of alcohol that acted pro-oxidatively in spite of our red
wine’s high phenolic content. The inverse relationship between
ORAC and CRP levels that reached significance after the diet
plus wine period (Fig. 5) suggests instead that the addition of red
wine-derived phenolics to the diet positively contributed towards
an anti-inflammatory effect.
Genotype effects
When considering the genetic risk factors implicated in the devel-
opment of arterial disease or thrombosis related to the β-fibrino-
gen 455G→A, PAI-1 –675 4G/5G and GPIIIa 1565T→C poly-
morphisms, the potential significance of combined genotypic
effects was highlighted. Half of the participants had 2 out of these
3 polymorphisms and 3 others had one of the 3 gene polymor-
phisms.
Three participants were heterozygous for the –455G→A poly-
morphism in the β-fibrinogen gene, while one was homozygous
for the A-allele. Two of the heterozygotes had persistently high
fibrinogen levels (>5.0 g/L) and in only one of these individuals
did the fibrinogen levels decrease after the diet with wine period.
The mean and median fibrinogen levels for the 4 participants with
the β-fibrinogen polymorphism were higher at baseline, after diet
and after diet and wine interventions compared to those of the 8
participants without this polymorphism and the former group
reacted less favourably on the interventions than the latter group
(Table 2).
Three of the study participants had the PIA2 or HPA-1b allele of
the 1565T→C polymorphism in exon 2 of the GPIIIa gene of
GPIIb/IIIa platelet surface receptor for fibrinogen binding. When
their platelet aggregation responses as maximum amplitude were
compared with those of the other 9 participants at base line, after
diet and after diet with wine interventions, their mean and medi-
an platelet aggregation responses with 5 µg/ml collagen were
much higher than those of the 9 participants without the poly-
morphism.
Eight of our study subjects had the 4G allele of the PAI-1 pro-
moter polymorphism, of whom 3 were homozygous for this
allele. PAI-1 levels did not differ between the 2 groups. Presence
of the 4G allele carries a higher risk for overweight or obesity and
may also explain the absence of response in the PAI-1 levels after
the interventions.
Although the findings were limited by the small number of sub-
jects studied over a relatively short period of time, some impor-
tant observations were made. Notably, the presence of the mutat-
ed allele of the GPIIIa polymorphism seems to prevent platelet
response to both interventions when compared to platelet
response of the participants before and after interventions as eval-
uated by the platelet aggregation with 5 µg/ml collagen. Similar
observations were made in relation to fibrinogen levels, as partic-
ipants with the β-fibrinogen polymorphism maintained the
increased fibrinogen levels after both interventions.
CONCLUSIONS
This short-term and intensive study included 12 participants with
positive markers of the metabolic syndrome whose responses to
intervention appeared to be affected by their genotype. The diet
and wine interventions increased the anti-oxidant potential of the
plasma and probably at intracellular level as reflected by the
platelets. The markers of inflammation and haemostasis did not
change significantly after the intervention periods due to the short
duration of the study, the already existing pathology in our target
subjects and the different reactions linked to specific genotypes as
discussed.
For future studies we recommend longer intervention periods
of diet with and without wine, a larger study population that
allows for comparison of response to the interventions between
larger genotypic subgroups.
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